Fundz

Syros Pharmaceuticals, Inc. reported raising $11.4 Million in an amended SEC Form D filing, from an offering of $11.4 Million

PRIVATEFeb 09, 2018

Amount Raised

$11.4 Million

$11.4 Million sold, per SEC Form D (first sale Feb 9, 2018)

Round Type

Venture

CambridgeBiotechnology

Quick answer

Syros Pharmaceuticals raised $11.4 Million in a funding round, dated February 9, 2018. Syros Pharmaceuticals is based in Cambridge, Massachusetts, United States.

How much did Syros Pharmaceuticals raise?
Syros Pharmaceuticals raised $11.4 Million in a funding round on February 9, 2018.
What does Syros Pharmaceuticals do?
Syros is redefining the power of small molecules to control the expression of genes.
Where is Syros Pharmaceuticals based and how big is it?
Syros Pharmaceuticals is based in Cambridge, Massachusetts, United States.
Who are the decision-makers at Syros Pharmaceuticals?
Fundz holds 1 contact at Syros Pharmaceuticals, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Syros Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Praxis Precision Medicines, Inc. raised $19M on March 26, 2018.
  • Cerecin raised $18M on March 26, 2018.
  • Purple Biotech raised an undisclosed amount on March 26, 2018.
  • IVIVA Medical, Inc. raised an undisclosed amount on March 26, 2018.
  • OXOS Medical raised $100K (Seed) on March 26, 2018.
  • SRX Global Inc. raised $777K (Seed) on March 26, 2018.

Who to call at Syros Pharmaceuticals, and when

A new round usually means Syros Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Syros Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Syros Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Syros Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Syros Pharmaceuticals

Location

35 CAMBRIDGE PARK DRIVE

Cambridge, Massachusetts, United States

About

Syros is redefining the power of small molecules to control the expression of genes. Based on its unique ability to elucidate regulatory regions of the genome, Syros aims to develop medicines that provide a profound benefit for patients with diseases that have eluded other genomics-based approaches. Syros is advancing a robust clinical-stage pipeline, including: tamibarotene, a first-in-class oral selective RARα agonist in RARA-positive patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide in patients with acute promyelocytic leukemia; and SY-5609, a highly selective and potent oral CDK7 inhibitor in patients with select solid tumors. Syros also has multiple preclinical and discovery programs in oncology and monogenic diseases. For more information, visit www.syros.com and follow us on Twitter (@SyrosPharma) and LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Syros Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMark A., Director hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Syros Pharmaceuticals's next move

See what Strategic adds

Syros Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.